CTLA4 and neoplasm: To obtain vaccinated splenocytes, 10^4 WT B16 tumor cells and 100μg/ml anti-CTLA4 antibody were administered to C57BL/6 mice on day 0, and splenocytes were collected at day 7 after tumor cell inoculation.